Model N Global Tender Management

Tender management capabilities are critical for manufacturers because at least 25% of pharma and 85% of medtech revenue is derived from tenders. Manufacturers that lack strong tendering capabilities can lose access to markets – with potential of being locked out from a provider for up to 36 months – causing irreparable effects on long-term market share and product profitability. The tools companies have traditionally used to manage tenders expose them to missed opportunities, unfavorable pricing, and supply chain misalignment. Model N Global Tender Management helps you maximize revenues by optimizing bids, aligning local and global resources in the tender process, and enabling you to capitalize on the benefits of a data-based approach to tendering. Unlike spreadsheet-based tools that require you to compile information manually, Global Tender Management enables users to look beyond local markets to understand tender performance at a global level. Because inaccurate projections can hamper efforts to craft competitive offers that win, Model N has included simulation tools like competitive scoring, market access data, and price transparency impact analysis.